Printer Friendly

CUSTOMEDIX REPORTS RESULTS

 CUSTOMEDIX REPORTS RESULTS
 OLDWICK, N.J., May 5 /PRNewswire/ -- Customedix Corporation


(AMEX: CUS; BSE: CUSB), a health care products company, today released the company's operating results for the third quarter and nine months ended March 31, 1992.
 Customedix incurred a net profit for the three month period ended March 31, 1992, of $290,026, or 9 cents per share, versus a net profit of $154,782, or 5 cents per share, for the corresponding quarter in fiscal 1991. In the nine month period ended March 31, 1992, the company recorded a net loss of $1,849,807, versus net income of $632,278 for the first three quarters of fiscal 1991. This 1992 year to date loss is a result of income from continuing operations of $343,699, offset by a $2,193,506 loss from the discontinued operations of Customedix's Automatic Injection Molding (AIM) subsidiary.
 Net sales for the three months ended March 31, 1992, were $9,935,342 versus $9,199,149 for the three months ended 1991, an increase of $736,193, or 8 percent. This increase is due to a general increase in sales over last year's comparable quarter. Sales for the first three quarters of fiscal 1992 were $27,107,636 versus $26,964,259 for last year's comparable period, for an increase of 0.5 percent. The net sales amounts above exclude AIM's net sales, which are included in the loss from discontinued operations.
 CUSTOMEDIX CORPORATION
 Condensed Consolidated Statements of Operations
 (unaudited)
 Periods ended Quarter Nine months
 March 31 1992 1991 1992 1991
 Net sales $9,935,342 $9,199,149 $27,107,636 $26,964,259
 Inc. from cont. opers.
 before taxes 385,028 345,867 515,201 1,045,650
 Taxes on income (A) 95,002 8,761 171,502 67,261
 Inc. from cont. opers. 290,026 337,106 343,699 978,389
 Loss from discont. opers.(C) --- (182,324) (2,193,506) (346,111)
 Net income (loss) 290,026 154,782 (1,849,807) 632,278
 Income per share from
 continuing operations $.09 $.10 $.10 $.30
 Net inc. (loss) per share .09 .05 (.56) .19
 Weighted avg. shares
 outstanding(B) 3,365,600 3,274,500 3,315,400 3,294,300
 Condensed Consolidated Balance Sheet
 March 31, 1992 June 30, 1991
 (unaudited) (audited)
 Assets
 Cash and equivalents $633,409 $684,495
 Receivables 5,412,106 6,331,197
 Inventories 4,976,033 5,663,415
 Assets of discontinued operations 325,785 ---
 Other 242,690 602,758
 Total current assets 11,590,023 13,281,865
 Property and equipment (net) 2,946,883 5,041,903
 Other 6,826,444 7,324,307
 Total assets 21,363,350 25,648,075
 Liabilities
 Payables and accrued expenses 2,445,504 3,469,218
 Accrued expenses for disposal of operations 345,104 ---
 Current maturities of long term debt and
 capitalized lease obligations 912,488 829,644
 Total current liabilities 3,703,096 4,298,862
 Long term debt and capitalized lease
 obligations 9,593,293 12,011,921
 Other --- 108,571
 Total liabilities 13,296,389 16,419,354
 Stockholders' equity:
 Common stock & additional paid-in capital 27,487,236 26,799,189
 Deficit (19,420,275) (17,570,468)
 Total stockholders' equity 8,066,961 9,228,721
 Total liabilities and stockholders' equity 21,363,350 25,648,075
 (A) -- Taxes on income are less than the statutory rate.
 (B) -- On Nov. 4, 1991, the shareholders voted to decrease the number of shares outstanding by effecting a one-for-ten reverse split of common stock. This action was given retroactive effect for all periods presented.
 (C) -- The results of the company's subsidiary, Automatic Injection Molding, Inc., have been discontinued as of Dec. 31, 1991, and have been excluded from the company's continuing operations for the periods compared.
 -0- 5/5/92
 /CONTACT: Dr. Gordon S. Cohen, chairman and CEO, or Barry L. Kosowsky, assistant treasurer, 203-265-7397, or Andrew A. Miller, CFO, 908-439-2226, all of Customedix/
 (CUS) CO: Customedix Corporation ST: New Jersey IN: HEA SU: ERN


PS-KD -- NY031 -- 6494 05/05/92 11:17 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 5, 1992
Words:681
Previous Article:LAFARGE CORPORATION DECLARES QUARTERLY CASH DIVIDEND
Next Article:ORTHO INTRODUCES NEW DISPOSABLE APPLICATORS FOR MONISTAT 7 CREAM MONISTAT 7 OTC OBSERVES FIRST YEAR WITH LEADERSHIP POSITION


Related Articles
CUSTOMEDIX REPORTS FIRST QUARTER FINANCIAL RESULTS
CUSTOMEDIX REPORTS RESULTS
CUSTOMEDIX REPORTS FISCAL FINANCIAL RESULTS FOR ITS FIRST QUARTER OF FISCAL 1993
CUSTOMEDIX CORPORATION REPORTS SETTLEMENT OF LITIGATION
CUSTOMEDIX REPORTS RESULTS
CUSTOMEDIX EXTENDS EMPLOYMENT AGREEMENT AND REPURCHASES SHARES FORM SUBSIDIARY OFFICER
CUSTOMEDIX CORPORATION BOARD APPROVES MERGER
Customedix Corporation Order and Final Judgment Entered in Delaware Litigation
Customedix Corporation Stockholders Approve Merger

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters